wy 41770 has been researched along with dinoprostone in 1 studies
| Studies (wy 41770) | Trials (wy 41770) | Recent Studies (post-2010) (wy 41770) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | wy 41770 (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlson, RP; Chang, J; Datko, LJ; Lewis, AJ; Nielsen, ST | 1 |
1 other study(ies) available for wy 41770 and dinoprostone
| Article | Year |
|---|---|
The antiinflammatory profile of (5H-dibenzo[a,d]-cyclohepten-5-ylidene)acetic acid (WY-41,770), an agent possessing weak prostaglandin synthetase inhibitory activity that is devoid of gastric side effects.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Carrageenan; Cyclooxygenase Inhibitors; Dibenzocycloheptenes; Digestive System; Dinoprostone; Edema; Fever; Hyperesthesia; In Vitro Techniques; Irritants; Lipoxygenase Inhibitors; Macrophages; Male; Platelet Aggregation; Pleurisy; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred Strains; Seminal Vesicles; Synovitis; Yeast, Dried | 1984 |